ACXP
Acurx Pharmaceuticals Inc.
$7.27
-$0.21(-2.81%)
51
Overall
60
Value
72
Tech
21
Quality
Market Cap
$6.50M
Volume
235.91K
52W Range
$3.80 - $42.80
Target Price
$27.00
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $12.8M | $12.1M | $14.6M | $14.1M | ||
| Research & Development | $2.0M | $4.8M | $6.0M | $5.4M | ||
| Research Expense | $2.0M | $4.8M | $6.0M | $5.4M | ||
| Selling, General & Administrative | $10.8M | $7.3M | $8.5M | $8.7M | ||
| General & Administrative Expenses | $10.8M | $7.3M | $8.5M | $8.7M | ||
| Salaries & Wages | $-5.2M | $-2.9M | $-3.2M | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-12.8M | $-12.1M | $-14.6M | $-14.1M | ||
| EBITDA | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| NON-OPERATING ITEMS | ||||||
| Other Income/Expense | $-66.5K | -- | -- | -- | ||
| Other Special Charges | $66.5K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| Pre-Tax Income | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| NET INCOME | ||||||
| Net Income | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| Net Income (Continuing Operations) | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| Net Income (Discontinued Operations) | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| Net Income (Common Stockholders) | $-12.7M | $-12.1M | $-14.6M | $-14.1M | ||
| Normalized Income | $-10.1M | -- | -- | $-14.0M | ||
| TOTALS | ||||||
| Total Expenses | $12.8M | $12.1M | $14.6M | $14.1M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $426.8K | $540.8K | $633.6K | $16.2M | ||
| Average Shares Outstanding (Diluted) | $426.8K | $540.8K | $633.6K | $16.2M | ||
| Shares Outstanding | $511.7K | $1.6M | $1.6M | $1.6M | ||
| Basic EPS | $-29.8 | $-22.4 | $-23 | $-0.87 | ||
| Basic EPS (Continuing Operations) | $-29.8 | $-22.4 | $-23 | $-0.87 | ||
| Diluted EPS | $-29.8 | $-22.4 | $-23 | $-0.87 | ||
| Diluted EPS (Continuing Operations) | $-29.8 | $-22.4 | $-23 | $-0.87 | ||
| OTHER METRICS | ||||||
| Net Income From Other Gains Losses | $66.5K | -- | -- | -- | ||
| Other Gand A | $10.8M | $7.3M | $8.5M | $8.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACXP | $7.27 | -2.8% | 235.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acurx Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW